The AHA today urged the Health Resources and Services Administration to meet the Jan. 1 effective date it has proposed for its final rule on drug ceiling prices and civil monetary penalties for manufacturers under the 340B Drug Pricing Program.
 
“We also urge that the policy changes made by the final rule, first published in January 2017, remain substantially unchanged,” AHA said today in comments on the proposed rule. 
 
Facing deadlines for responding to a lawsuit brought by the AHA, Association of American Medical Colleges, America's Essential Hospitals, 340B Health and three hospital systems, HRSA Oct. 31 proposed the regulation to change the effective and compliance date to Jan. 1.
 
In its comments, AHA also urged the agency to make pricing information available to 340B hospitals and other participating providers online through a secure website, which is required by the final rule, “available as soon as possible after the effective date.”
 

Related News Articles

Headline
The Department of Health and Human Services’ Office of the National Coordinator for Health Information Technology today released an updated Trusted Exchange…
Headline
The AHA today voiced support for the Recovering Excessive Funds for Unused and Needless Drugs Act (S. 551), legislation that would incentivize manufacturers to…
Headline
The Federal Trade Commission will hold a public workshop June 18 in Washington, D.C., to assess the impact of certificates of public advantage on health care…
Headline
In a letter to the editor, AHA today expressed concerns with a recent Modern Healthcare article presenting the findings of a study on health system…
Chairperson's File
During this National Minority Health Month, I encourage you all to learn more about the health status of racial and ethnic minority populations in the U.S. and…
Headline
The Medicaid and CHIP Payment and Access Commission yesterday recommended that Congress change the definition of Medicaid shortfall to exclude costs and…